首页> 美国卫生研究院文献>Turkish Archives of Pediatrics/Trk Pediatri Aivi >Hematopoetic stem cell transplantation in children
【2h】

Hematopoetic stem cell transplantation in children

机译:小儿造血干细胞移植

代理获取
本网站仅为用户提供外文OA文献查询和代理获取服务,本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文,但由于OA文献来源多样且变更频繁,仍可能出现获取不到、文献不完整或与标题不符等情况,如果获取不到我们将提供退款服务。请知悉。

摘要

Bone marrow transplantation is called hematopoetic stem cell transplantation (HSCT), since peripheral blood and umbilical cord blood can also be used as sources of stem cell currently. In children, bone marrow transplantation is used as a definite treatment method in many diseases including hemoglobinopaties, immune deficiencies, bone marrow failure and congenital metabolic diseases in addition to hematological malignancies. In addition to the underlying disease, the most important factors which have an impact on prognosis include infections which develop during the process of transplantation and graft-versus-host disease. In this article, it was aimed to give brief information on stem cell sources, preparation therapies, HSCT indications and post-transplantation complications in children.
机译:骨髓移植称为造血干细胞移植(HSCT),因为目前外周血和脐带血也可以用作干细胞的来源。在儿童中,除血液系统恶性肿瘤外,骨髓移植还被用作许多疾病的明确治疗方法,包括血红蛋白缺乏症,免疫缺陷,骨髓衰竭和先天性代谢疾病。除潜在疾病外,影响预后的最重要因素还包括在移植过程中发生的感染以及移植物抗宿主病。本文旨在提供有关儿童干细胞来源,制备疗法,HSCT适应症和移植后并发症的简要信息。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
代理获取

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号